Ganglioglioma differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ganglioglioma}} | {{Ganglioglioma}} | ||
{{CMG}}{{AE}}{{SR}} | |||
==Overview== | |||
==Differentiating Ganglioglioma from other Diseases== | |||
Ganglioglioma must be differentiated from: | |||
dysembryoplastic neuroepithelial tumours (DNET) | |||
contrast enhancement uncommon | |||
'bubbly appearance' common | |||
pleomorphic xanthoastrocytoma (PXA) | |||
contrast enhancement prominent | |||
dural tail sign often seen | |||
oligodendroglioma | |||
calcifications common | |||
desmoplastic infantile ganglioglioma | |||
young children | |||
dural involvement prominent | |||
large often multiple lesions | |||
If in the spinal cord consider: | |||
astrocytoma | |||
ependymoma | |||
==References== | ==References== |
Revision as of 21:10, 3 September 2015
Ganglioglioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ganglioglioma differential diagnosis On the Web |
American Roentgen Ray Society Images of Ganglioglioma differential diagnosis |
Risk calculators and risk factors for Ganglioglioma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Differentiating Ganglioglioma from other Diseases
Ganglioglioma must be differentiated from: dysembryoplastic neuroepithelial tumours (DNET) contrast enhancement uncommon 'bubbly appearance' common
pleomorphic xanthoastrocytoma (PXA) contrast enhancement prominent dural tail sign often seen
oligodendroglioma calcifications common
desmoplastic infantile ganglioglioma young children dural involvement prominent large often multiple lesions
If in the spinal cord consider:
astrocytoma ependymoma